These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10440288)

  • 1. PUVA treatment of vitiligo: a retrospective study of Turkish patients.
    Sahin S; Hindioğlu U; Karaduman A
    Int J Dermatol; 1999 Jul; 38(7):542-5. PubMed ID: 10440288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of vitiligo to PUVA therapy in Saudi patients.
    Tallab T; Joharji H; Bahamdan K; Karkashan E; Mourad M; Ibrahim K
    Int J Dermatol; 2005 Jul; 44(7):556-8. PubMed ID: 15985023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
    Sapam R; Agrawal S; Dhali TK
    Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of vitiligo with PUVA-pigmented autologous epidermal grafting.
    Suga Y; Butt KI; Takimoto R; Fujioka N; Yamada H; Ogawa H
    Int J Dermatol; 1996 Jul; 35(7):518-22. PubMed ID: 8809611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.
    Ermis O; Alpsoy E; Cetin L; Yilmaz E
    Br J Dermatol; 2001 Sep; 145(3):472-5. PubMed ID: 11531839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches.
    Parsad D; Pandhi R; Dogra S; Kumar B
    J Am Acad Dermatol; 2004 Jan; 50(1):63-7. PubMed ID: 14699367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study.
    Kwok YK; Anstey AV; Hawk JL
    Clin Exp Dermatol; 2002 Mar; 27(2):104-10. PubMed ID: 11952699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.
    Hegyi V; Petrovajová M; Novotný M
    Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of repigmentation in two cases of hypopigmented type of vitiligo.
    Anbar TS; El-Sawy AE; Attia SK; Moftah NH; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):156-8. PubMed ID: 19438996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of psoralen photochemotherapy for vitiligo.
    Chuan MT; Tsai YJ; Wu MC
    J Formos Med Assoc; 1999 May; 98(5):335-40. PubMed ID: 10420701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
    Natta R; Somsak T; Wisuttida T; Laor L
    J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of stable vitiligo with autologous epidermal grafting and PUVA.
    Hann SK; Im S; Bong HW; Park YK
    J Am Acad Dermatol; 1995 Jun; 32(6):943-8. PubMed ID: 7751463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol and PUVA as treatment for vitiligo.
    Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
    Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    Oakley AM
    Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.